Liminatus Pharma, Inc. (LIMN) stock
LIMNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMNW
$2.99+0.22 (+7.94%)
Close on Nov 13, 2026Market cap $200.81MP/E –Yield –
Liminatus Pharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Liminatus Pharma's enterprise value was $162.98M on Nov 11, 2026, against $1.41B a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $162.98M | -80.3% |
| 2025 | Dec 31, 2025 | $826.19M | – |
See a number that looks wrong?